AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Siaglide-M OD 100mg/500mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Siaglide-M OD 100mg/500mg Tablet PR

Combiflex-D 100mg/500mg tablets are a dual-action medication managing elevated blood glucose in type 2 diabetes patients. This helps mitigate serious diabetic complications like nephropathy and retinopathy, potentially lowering heart attack and stroke risk. Combiflex-D 100mg/500mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized, considering your health status, blood sugar readings, and other medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily intake at the same time maximizes effectiveness; discontinuation requires physician approval. Adherence to the prescribed diet and exercise plan is crucial for effective diabetes management; lifestyle choices are integral to blood sugar control. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, and pharyngitis. Hypoglycemia is a potential side effect when used with insulin or sulfonylureas; learn how to identify and manage this complication. This medication isn't suitable for all individuals. Inform your doctor of any prior kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before commencing treatment. Pregnant or lactating individuals must consult their physician before use. Interactions with other medications are possible; disclose all your medications to your doctor to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Siaglide-M OD 100mg/500mg Tablet PR

Managing type 2 diabetes

Major Benefits of Siaglide-M OD 100mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for dosage information. Administer Siaglide-M OD 100mg/500mg tablets post-prandially.

Common Side effects of Siaglide-M OD 100mg/500mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siaglide-M OD 100mg/500mg Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take Siaglide-M OD 100mg/500mg tablets with food.

How Siaglide-M OD 100mg/500mg Tablet PR works:

Siaglide-M 100mg/500mg tablets (once daily) combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Siaglide-M OD 100mg/500mg Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Siaglide-M OD 100mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Siaglide-M OD 100mg/500mg tablets during breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with severely low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Siaglide-M OD 100mg/500mg Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Siaglide-M OD 100mg/500mg Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Siaglide-M OD 100mg/500mg tablets is likely unsafe for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Siaglide-M OD 100mg/500mg Tablet PR :

Should you forget a Siaglide-M OD 100mg/500mg Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Siaglide-M OD 100mg/500mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Siaglide-M OD 100mg/500mg Tablet PR

Siaglide-M OD 100mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Siaglide-M OD 100mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological symptoms such as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Siaglide-M OD 100mg/500mg Tablet PR commonly causes hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Siaglide-M OD 100mg/500mg Tablets are contraindicated in patients allergic to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siaglide-M OD 100mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Siaglide-M OD 100mg/500mg) can cause lactic acidosis (MALA), a serious medical condition involving excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siaglide-M OD 100mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years of age.
Siaglide-M OD 100mg/500mg Tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Siaglide-M OD 100mg/500mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Siaglide-M OD 100mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Siaglide-M OD 100mg/500mg Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siaglide-M OD 100mg/500mg Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Siaglide-M OD 100mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Siaglide-M OD 100mg/500mg Tablet PR commonly causes hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to Siaglide-M OD 100mg/500mg Tablet PR components or excipients should not use it. This medication is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siaglide-M OD 100mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin/Metformin (Siaglide-M OD 100mg/500mg Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Siaglide-M OD 100mg/500mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Siaglide-M OD 100mg/500mg...
284